Iraqi National Charged in Multi-National Terror Plot Targeting U.S. And Israeli Interests
Federal prosecutors have charged an Iraqi national, Mohammad Baqer Saad Dawood al-Saadi, in connection with at least 18 reported terrorist attacks in Europe and a conspiracy to target institutions within the United States. The charges allege that Al-Saadi sought to retaliate for the war in Iran and attempted to disrupt American society through violence and intimidation.
Alleged Terror Campaign Across Europe
According to a federal criminal complaint, Al-Saadi allegedly carried out a series of terrorist attacks in Europe targeting U.S. And Israeli interests. These actions were reportedly intended to halt the ongoing conflict in Iran.
The complaint details several specific incidents occurring in major European cities:
- Amsterdam: An alleged firebombing of a Bank of New York Mellon building.
- Paris: An attempt to detonate improvised explosives at a Bank of America building.
- London: The stabbing of two individuals.
Plot to Target U.S. Institutions
Beyond the attacks in Europe, federal authorities allege that Al-Saadi attempted to expand his operations to the United States. Prosecutors claim that Al-Saadi engaged with an FBI undercover agent and paid $3,000 to plan attacks in California, Arizona, and at a synagogue in Manhattan.
During his initial appearance in Manhattan federal court on Friday, Al-Saadi reportedly spoke to his lawyer, Andrew Dalack, regarding his connection to the late Iranian General Qasem Soleimani, who was killed in a U.S. Strike in Iraq. During the proceedings, Al-Saadi allegedly referred to himself as a political prisoner and a prisoner of war.
Terrorist Affiliations and Background
Federal prosecutors have identified Al-Saadi as a high-level member of the Kata’ib Hizballah paramilitary group. The criminal complaint further alleges that he maintains ties to both Hezbollah and the Iran Revolutionary Guard Corps (IRGC).
Legal Proceedings and Next Steps
Al-Saadi was apprehended in Turkey and subsequently turned over to American authorities. He currently remains in custody following a court order for his detention. He faces a host of charges, including:
- Conspiracy to provide material support to terrorist groups.
- Conspiracy to bomb a place of public use.
- Other related federal offenses.
Al-Saadi is scheduled for his next court appearance on May 29.
Key Takeaways
- Suspect: Mohammad Baqer Saad Dawood al-Saadi, a high-level member of Kata’ib Hizballah.
- European Attacks: At least 18 reported attacks, including firebombing in Amsterdam and stabbings in London.
- U.S. Plot: Alleged conspiracy to attack locations in California, Arizona, and a Manhattan synagogue.
- Status: Apprehended in Turkey. next court date is May 29.
Keep reading
- 2027 COTA January Service Change Public Meeting | Columbus
- PhD Position in Architectural Representation at TU Dresden
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)